Hepatocyte nuclear factor (HNF) 1 is a key transcription factor Involved in the expression of many llver-speclflc genes. We have Isolated and characterized the promoter region of the rat HNF1 gene. Transfectlon experiments revealed that a short region between -118 and -8 Is crucial for cell type-specific expression of the HNF1 gene in the hepatoma cell line, HepG2 cells. This region contains two positive cls-elements: site A, to which the transcription factor HNF4 protein can bind, and site B, to which the HNF1 protein can bind. Mutatlonal analyses of these sites and cotransfectlon assays suggested that the HNF4 protein and HNF1 protein can transactlvate the HNF1 gene.
INTRODUCTION
In higher organisms, the genes involved in terminal differentiation become activated during development in a highly cell type-specific manner. This selective induction of gene activity is governed by transcriptional regulator proteins that are themselves tissuespecifically regulated (1) (2) (3) (4) . Several key transcription factors in the liver have been identified and cloned; namely, hepatocyte nuclear factor(HNF)l, the homeodomain protein (5), C/EBP, the leucine-zipper protein (6) , HNF3, the fork head domain protein (7) , and HNF4 protein, a member of the steroid hormone receptor superfamily (8) . HNF1 protein-binding sites have been identified in many liver-specific genes (9) and deletions of these sites have shown that the HNF1 protein is a key regulatory protein for gene expression in the liver.
Using a specific antibody for the HNF1 protein, we previously analyzed the developmental profile of the HNF1 protein in mouse embryos and found that the HNF1 protein appears in developing liver on day 10.5 of gestation (10) . Since the tissue-specific distribution of HNF1 is based on the level of its transcription, the question arises of how the expression of the HNF1 gene itself is tissue-specifically regulated.
In this study we isolated the HNF1 gene and analyzed its promoter region. By transient transfection, DNase I footprint, and electrophoretic mobility shift assays, two cis-elements, HNF4-and HNF 1-binding sites, were identified upstream of the transcription initiation site. These sites appear to have crucial roles in cell type-specific transcription of the HNF1 gene.
MATERIALS AND METHODS

Cloning of the rat hepatocyte nuclear factor (HNF)1 gene
We screened a rat liver genomic library with die EcoRI-SacI fragment of pHF 22.1 (10) as a probe and obtained 11 positive clones. After hybridization analysis with the EcoRI-SacI fragment of pHF 22.1, a 9 kbp Xhol fragment containing the translation initiation codon was subcloned into Bluescript KS(+) and further analyzed. The nucleotide sequence of the 5' flanking region of the gene was determined in both directions by the dideoxy chain termination method with Sequenase (USB) using T3 primer, T7 primer and synthesized oligonucleotides as sequencing primers.
Primer extension and RNase protection analyses
Total RNA and poly A + RNA were prepared from rat liver as described previously (11) . Primer extension analysis and RNase protection analysis of the HNF1 mRNA were performed as described previously (12,13). The oligonucleotide used for primer extension had the sequence 5'-GGCAGTCAACGGACCAGGC-TCGCTGCACCCACTGCTCCCC-3'. The riboprobe for RNase protection was generated using T7 polymerase and [ a-32 P]UTP (800Ci/mmol) from Bluescript SK(+), which contained the SmalXhol fragment (nucleotides -390/+272) and was cut at the StuI site (nucleotide position -73).
Cell cultures and preparations of nuclear extracts
HepG2 cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal calf serum (FCS); P19 cells were cultured in alpha minimal essential medium (aMEM) containing 10% FCS. Nuclear extracts from the cultured cells were prepared as described previously (14) . The protein concentrations of the extracts were determined by the method of Bradford (15) .
Constructions of HNF1 promoter deletions and other plasmid DNAs
The Nhel-Nhel fragment (-2. lk/+180) and Xhol-Spel fragment (-9.0k/+92) of the 9 kbp Xhol fragment described above were subcloned into the pSV0AAL5' plasmid (16; kindly provided by Dr S. Subramani) with suitable connectors. The PCR products amplified between the sense primers at -516, -394, -257, -118, -36, and -8 and the antisense primer at +58 were subcloned into pSV0AAL5' and their sequences were confirmed by sequence analysis. ) and the reverse transcriptase-extended products were analyzed in a 6% sequencing gel. The arrow indicates the major initiation site. C, RNase protection assay of HNF1 mRNA. The labeled riboprobe (lane 5) was annealed with 10 p% of yeast tRNA (lanes 6 and 7), or 10 /ig (lanes 7 and 8) or 30 ^g (lanes 9 and 10) of total liver RNA. After digestion with RNases Tl and A, the protected materials were separated in a 6% sequencing gel. Sequencing ladders were used as precise size markers. One major (large arrow) and one minor (small arrow) protected band are seen.
The following oligodeoxynucleotides were synthesized in a 391 PCR-MATE DNA synthesizer (Applied Biosystems, CA): Site-specific mutations were introduced into the HNF1 promoter as follows: The -516/+58 fragment of the HNF1 promoter was ligated into the HindTJI, Xhol-digested mp 18X RF DNA (the Smal site was converted to a Xhol site) and singlestranded DNA was prepared. In vitro mutagenesis was carried out using an oligonucleotide-directed system (RPN 1523, Amersham Corp.) according to the protocol of the supplier. The oligonucleotides, mt(site A) and mt(site B), were used for making AA and Bmut mutants, respectively. All mutations were confirmed by sequence analysis and the mutated DNAs were ligated into the pSV0AAL5' plasmid.
Transfection of DNA into cultured cells and measurement of luciferase and CAT activities
Mixtures of 5 ng of the HNF1 promoter-luciferase constructs, 3 fig of pSV2CAT, various amounts of CMV-HNF1 and EF-HNF4 plasmids, and pCAGGS to give a total of 15 ng were transfected into HepG2 cells and P19 cells by a modification of the calcium phosphate coprecipitation method described by Chen and Okayama (21) . When TK-CAT constructs were used as reporter genes, 5 /tg of the oligonucleotide-TKCAT constructs, 3 ng of pSV2L, various amounts of CMV-HNF1 and EF-HNF4 plasmids, and the pCAGGS vector to give a total of 15 ng were transfected into the cells. The cells were incubated for 16 to 20h with calcium phosphate-precipitated DNAs, washed twice with phosphate-buffered saline and cultured in fresh medium. Cellular protein extracts were made 24 to 36h later by three cycles of freeze-thawing, cellular debris was removed by centrifugation, and the protein concentration was determined by the method of Bradford. The luciferase and CAT activities of the extracts were determined as described previously (16, 22) . For normalization of the transfection efficiency, the luciferase activity of the test constructs was corrected for the control CAT activity, and vice versa.
DNase I footprint analysis and electrophoretic mobility shift assay
The PCR products amplified between -198 and +58, which contained HindTTI and Xhol sites, respectively, at the two ends, were subcloned into Bluescript SK(+). The plasmids were labeled at the Xhol site with T4 polynucleotide kinase and [ Y-^PJATP (6000Ci/mmol) and recut at the Hindin site, or vice versa for the opposite strand. These labeled fragments were purified in a 6% native poly aery lamide gel. DNase I protection was performed as described previously (23) .
The double-stranded oligonucleotides were labeled with T4 polynucleotide kinase and [ 7- 32 P]ATP. Then 0.5 ng of labeled probe was incubated with 10 /ig of the nuclear extracts in 20 /d of 10 mM HEPES-KOH (pH 7.9), 50 mM KC1, 2mM EDTA, 1 mM DTT, 10% glycerol and poly(dI-dC)/poly(dI-dC) (0. 25  fig/fd ) at 30°C for 30 min. The reaction mixtures were applied to a 5% native polyacrylamide gel (80:1 acrylamide/bisacrylamide) in 0.25 xTris-Borate-EDTA and after electrophoresis, the gels were dried and autoradiographed.
RESULTS
The transcription factor HNF1 plays a critical role in the expression of many hepatocyte-specific genes. Since control of the tissue-specific distribution of HNF1 is at the transcriptional level, we tried to isolate the HNF1 promoter region and determine its regulation. Analysis of me HNF1 promoter region should allow identification of the transcription factors that are important for establishment of hepatocyte differentiation.
To isolate the HNF1 gene, we screened a rat genomic library with a labeled EcoRI-SacI fragment containing the 5' portion of the HNF1 cDNA (nucleotides 39 to 181; 5). The 11 positive genomic clones obtained were further characterized by probing Southern blots of the clones with a variety of labeled oligonucleotides spanning the length of the cDNA. This analysis revealed that the 9 kbp Xhol fragment contained the translation initiation codon and the 5' flanking region. The 9 kbp Xhol fragment of the DNA was subcloned into Bluescript KS(+), and the nucleotide sequence of the promoter region was determined (Fig. 1A) . First, we examined the location of the transcription initiation site within the HNF1 gene by primer extension assay with an antisense oligonucleotide on poly A + RNA from rat liver. As shown in Fig. IB , one major primer-extended product was detected in liver mRNA (lane 5), but not in yeast tRNA (lane 6) . From this analysis, we mapped the precise position of the start of transcription at nucleotide A shown by an arrow in Fig. 1A . To confirm the transcription initiation site, we performed an RNase protection assay on labeled riboprobe of the Stul-Xhol fragment (probe size; 370 b long) using liver RNA. As seen in Fig. 1C , one major (276b long) and one minor (266b long) protected band were detected in liver RNA (lanes 8-11), but not in tRNA Qanes 6 and 7). The major band corresponded in size to that expected from the primer extension assay. From these results we concluded that the major transcription initiation site is located 222 nucleotides upstream of the translation initiation codon.
To identify the region that is important for gene expression in the HNF1 promoter, we attached various lengths of the 5' flanking region to the luciferase gene, and transfected these constructs into HepG2 cells (HNF1 positive)(10) and P19 cells (HNF1 negative)(10) by calcium phosphate coprecipitarion, using pSV2CAT as an internal control of transfection efficiency. The luciferase activities of extracts of HepG2 cells transfected with the promoter having 5' deletions up to -118 were high and quite similar. However, deletion of the DNA to -36 resulted in a dramatic decrease in luciferase activity. Further deletion to -8 resulted in half the activity of the -36 construct (Fig. 2 A, open  bars) . In contrast, none of the constructs showed any luciferase activity when transfected into P19 cells (Fig. 2A, closed bars) .
These results indicate that the 5' flanking region of the HNF1 promoter shows tissue-specific expression and that the region between -118 and -8 is important for expression of the HNF1 gene in HepG2 cells.
We investigated the nuclear proteins binding to the -118/ -8 region that are important for transactivation in HepG2 cells by DNase I footprint analysis of the fragment as described in Materials and Methods. For this analysis, we incubated the endlabeled fragment with nuclear extracts from the HepG2 cells and then examined for DNase I protection. As shown in Fig. 2B , two sites, termed A and C, were protected when small amounts of the nuclear extract were used (lanes 5 and 6). An additional site, named B, was also protected when a larger amount of the extract was used (lanes 7 and 8). However, nuclear extracts from the P19 cells did not give protection at site A, B or C (data not shown). The nucleotide sequences of the protected regions are underlined in Fig. 1 A. Inspection of the sequence of the protected regions suggested that the sequence of site A is similar to that to which the liver-enriched transcription factor HNF4 binds (8) while that of site B resembles the HNF1 protein-binding site (9) . As we could not find candidate factors which could bind to site C, we examined the proteins binding to sites A and B. Using an electrophoretic mobility shift assay, we first investigated whether HNF4 could bind to site A in the HNF1 promoter (Fig. 2C ). After incubation with the nuclear extract from HepG2 cells, the she A oligonucleotide gave one prominent retarded band (lane 2). Addition of increasing amounts of cold homologous site A oligonucleotide resulted in disappearance of this band (lanes 3-5). Addition of site 4 oligonucleotide, corresponding to the HNF4-binding site in the human apoCDI gene (8) , to the reaction mixture also resulted in disappearance of the retarded band (lanes 9-11). Addition of site 1 oligonucleotide, corresponding to the HNF 1-binding site in the rat fibrinogen gene (24), did not affect the band Qanes 6-8). Similar results were obtained using the site 4 oligonucleotide as a labeled probe (data not shown). Next, we examined whether the HNF1 protein binds to site B (Fig. 2D) . When nuclear extracts of HepG2 cells were incubated with the site B probe, one major retarded band was observed (lane 2, arrow). When the probe was incubated in the presence of excess amounts of the same cold oligonucleotide, the retarded band disappeared Qane 3). In the presence of an excess of the site 1 oligonucleotide, formation of the complex was greatly diminished (lane 4). However, incubation of the probe in the presence of excess site 4 oligonucleotide did not affect the formation of the retarded band (lane 5). Also when the Bmut oligonucleotide, which has three mutations in the binding site, was used as a labeled probe, no retarded complexes were detected (data not shown).
Then we determined whether site A and/or site B acted as positive cis-elements. For this, we introduced the synthesized oligonucleotides into the TK-CAT gene and transfected the constructs into HepG2 cells and P19 cells. Insertion of a single copy of the site A or site B oligonucleotide increased the CAT activity 3.4-fold and 4.6-fold, respectively (Fig. 2E, lanes 2 and  3 vs. lane 1) . However, insertion of the Bmut oligonucleotide did not increase the transcriptional activity (lane 4). Transfection of these three oligonucleotide-TKCAT constructs into P19 cells did not increase the activity (Fig. 2E, lanes 6-8) . These results suggest that site A to which die HNF4 protein binds and site B to which the HNF1 protein binds act as positive cis-elements for the HNF1 promoter in HepG2 cells. Next we examined whether sites A and B in the natural promoter could act as positive cis-elements. First, we made mutant promoter-luciferase constructs in which only site A or site B was mutated, and transfected these two mutant and the wild type constructs into HepG2 cells. The luciferase activities of the transfected cells were compared (Fig. 3A) . The AA mutant, in which site A was deleted, showed markedly reduced transcriptional activity. The Bmut mutant, in which the sequence of site B was mutated, also showed significantly reduced activity (Fig. 3A) . This experiment showed that sites A and B act as positive cis-elements in the natural HNF1 promoter. Finally, we examined whether the HNF4 and HNF1 proteins transactivated the HNF1 promoter. As P19 cells have no HNF4 or HNF1 protein, we cotransfected these cells with the HNF1 promoterluciferase construct and combinations of the HNF1-and HNF4-expression vectors (Fig. 3B, left panel) . Upon transfection of increasing amounts of the HNF1-expression plasmid, the transcriptional activity increased up to 12-fold (open bars). When one ng equivalent of the HNF4-expression plasmid was transfected, the activity was increased by a factor of 20. On cotransfection of increasing amounts of the HNF1-expression vector and a constant amount of the HNF4-expression vector, the activity increased dramatically up to 124-fold (closed bars). Next, we transfected the Bmut mutant promoter-luciferase construct instead of the wild type promoter construct with combinations of the HNF1-and HNF4-expression plasmids (Fig. 3B, right panel) . Transfection of the HNF1-expression vector showed little increase in transcriptional activity (up to 1.9-fold, open bars). Transfection of one fig equivalent of the HNF4-expression vector increased the activity 7.5-fold. Upon cotransfection with increasing amounts of the HNF1-expression plasmid and a constant amount of the HNF4-expression plasmid, the transcriptional activity increased a little (up to 13-fold, closed bars). These data indicate that the HNF4 protein and the HNF1 protein play crucial roles in activating the HNF1 gene.
DISCUSSION
To elucidate the molecular basis for tissue-specific expression of genes in the liver, we isolated genomic clones encompassing the HNF1 gene promoter, the key regulator of liver-specific gene expression, and examined its functional characteristics by transient transfection experiments. In assays using deletions of the HNF1 promoter, we found that a relatively short DNA segment located between -118 and -8 is responsible for its cellspecific transcription. This segment was found to contain two important positive cis-elements: site A, to which the liverenriched transcription factor, HNF4 protein, can bind, and site B, to which HNF1 protein can bind. HNF4 mRNA is present in the liver, kidney, and intestine and the distribution of HNF4 overlaps that of HNF1 (25) . Insertion of site A and site B oligonucleotides into a heterologous promoter resulted in marked transactivation of the gene (Fig. 2E, lanes 2 and 3) . Mutation of site B (site Bmut) abolished the transactivation activity of the site (Fig. 2E lane 4) . These results suggest that both site A and site B are positive cis-elements for the HNF1 gene.
The transcriptional regulations of several genes encoding tissuespecific transcription factors have been studied. These include Pit-l/GHF-1, an anterior pituitary gland-specific POU domain protein (26, 27) , MyoD, a muscle-specific helix-loop-helix protein (28) , the erythroid factor GATA-1 (29) , and the liver factor HNF30 (30) . In all these cases, the transcription factor can apparently autoregulate its own expression by binding to the promoter of its own gene. Our results indicate that transcriptional control of the HNF1 gene is mainly by hetero-regulation (activation of the HNF1 gene by liver-enriched HNF4 protein) in addition to autoregulation by the HNF1 protein.
Recently the promoters of the rat (31) and mouse (32) HNF1 genes were isolated by two independent groups. The transcription initiation sites of the genes reported by these groups were different to each other and also differ from the site identified in our study, for some unknown reason. They mapped it to +10 (in ref. 31) and +43 (in ref. 32) in Fig. 1A by SI nuclease protection and RNase protection, respectively. We have mapped this site precisely by both primer extension and RNase protection analyses. The initiation site reported by Tian and Schibler (31) could correspond to our minor initiation site (Fig. 1Q . In these previous reports (31, 32) it is suggested that HNF4 is the most important protein for activation of both the rat and mouse HNF1 gene, and our findings are consistent with this conclusion. However, in addition to this HNF4-binding site (site A), we have found a HNF1-binding site (site B) just downstream of the HNF4-binding site, and show that it is also important for activation of the HNFl gene. In cotransfection experiments into P19 cells, the HNFl protein alone could transactivate the natural HNFl promoter (Fig. 3B left panel, open bars) . Interestingly, the HNFl and HNF4 proteins together dramatically increased the transactivating activity (Fig. 3B left panel, closed bars) . This synergistic action of the two proteins was not observed when the mutant promoter in which site B was mutated was used ( Fig. 3B  right panel) . Our results suggest that sites A and B are both important for activation of the HNFl gene. The use of larger amounts of nuclear extract for DNase I footprinting and the use of a strong promoter (CMV promoter) for the transactivation experiments might have enabled us to find site B, which the previous reports could not.
Both sites may be important in regulation of the HNFl gene in liver development. The message of vHNFl, another member of the HNFl family, is present in developing liver on day 10 of gestation (33) and precedes the appearance of HNFl mRNA (34) . No data are available on the profile of HNF4 expression during liver development. Since the vHNFl protein can also bind to the HNFl-binding site of /S-fibrinogen, a r antitrypsin and albumin genes (35) (36) (37) , conceivably it might bind to site B on the HNFl promoter and interact cooperatively with HNF4 protein at site A. After the appearance of HNFl mRNA, the mechanism of posttranscriptional regulation seems to act on vHNFl mRNA in the liver (35) . The relationships among the HNFl, vHNFl, and HNF4 genes need to be examined by further experiments, including studies on the HNF4 message in the liver of embryos by in situ hybridization, in vitro transcription studies using recombinant vHNFl, HNFl, and HNF4 proteins, and studies on inactivation of the vHNFl, HNFl, and HNF4 genes in mice by homologous recombination.
